Engaging in difficult conversations is central to the work of an oncologist, but it is a process that many still struggle with, in part due to a gap in training. The ultimate goal of communication skills training is to improve patient outcomes.
The treatment paradigm of breast cancer has celebrated the successes of targeted therapy for decades. Currently, the hormone receptor and HER2 statuses of a breast tumor continue to drive the selection of therapy for patients with early-stage breast cancer and metastatic breast cancer (mBC).
Cancer care for patients is a universal right; however, patient care is continually challenged by changing government policies, socioeconomic gaps, and the inability to enact facilitated collaboration between medical professionals.
ASCO’s recent release of resource-stratified guidelines for the prevention and treatment of invasive cervical cancer has provided valuable guidance to low- and middle- income countries (LMICs), where approximately 85% of cervical cancer cases occur.
Rare genitourinary neoplasms encompass diseases of the kidney, bladder, prostate, and penile tract that are of uncommon histology. These entities often pose a major diagnostic and treatment dilemma to the treating physician.
Evidence from multiple positive trials, support from literature reviews and editorials, and the endorsements of professional societies and funding agencies all promote the use of patient-reported outcomes (PROs) in clinical cancer care.
After two recent clinical trials provided long-awaited new information on the role of lymph node management in patients with melanoma, a panel was formed to update the 2012 ASCO-Society of Surgical Oncology (SSO) guidelines for sentinel lymph node (SLN) biopsy.
Mortality-extending strategies in the management of head and neck neoplasms are critically important—but preservation of the larynx is also highly desirable, as maintaining a functioning voice and swallowing conduit is vital to a patient’s quality of life.